Alzheimer’s Retinal Exams; Convicted Neurologist Dies; Another ALS Drug Heads to FDA

Several different retinal exams are being evaluated as potential ways to screen for Alzheimer’s disease. (Scientific American)

Varicella zoster virus may play a role in Alzheimer’s by reactivating herpes simplex virus type 1, lab studies suggested. (Journal of Alzheimer’s Disease)

Better use of comprehensive epilepsy care, diagnostic services, and medications were each linked with reduced mortality among U.S. veterans with drug-resistant epilepsy. (JAMA Neurology)

Weeks after being convicted of sexually assaulting his patients, New York neurologist Ricardo Cruciani, MD, was found dead in jail. (NBC News)

Magnetic resonance spectroscopy showed why thinking makes you tired. (Current Biology)

The age at onset of relapsing-remitting multiple sclerosis (MS) has increased in the last five decades. (Multiple Sclerosis and Related Disorders)

Retinal layer thinning after optic neuritis was linked with future MS relapse remission. (Neurology)

Chronic kidney disease was associated with higher risk of intracerebral hemorrhage across two observational studies. (JAMA Neurology)

Researchers replicated a brain age model that predicted future cognitive changes. (Molecular Psychiatry)

Physical, cognitive, and social activities were inversely associated with incidence of all-cause dementia, a meta-analysis showed. (Neurology)

BrainStorm Cell Therapeutics corrected its analyses of phase III trial data for its investigational ALS stem-cell treatment NurOwn and plans to submit a biologics license application to the FDA.

What should goals for diverse recruitment in Alzheimer’s clinical trials be? (JAMA Neurology)